NK cell desensitization can occur when the activating receptors represented by NKG2D are persistently stimulated by ligands on tumor cell surfaces without simultaneous engagement of inhibitory receptors, inducing a hyporesponsive state [31, 32]. The gene discussed is KLRK1; the disease is neoplasm.